Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rapid disappearance of both severe atopic dermatitis and cold urticaria following dupilumab treatment

Published:2019-09-12 Issue:3 Volume:45 Page:345-346
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Ferrucci S.¹,Benzecry V.¹²,Berti E.¹²,Asero R.³

Affiliation:

1. Complex Operative Unit of Dermatology Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan Italy

2. Department of Pathophysiology and Transplantation University of MilanFoundation IRCCS Cà Granda Ospedale Maggiore Policlinico Milan Italy

3. Allergy Unit Clinica San Carlo Paderno Dugnano Milan Italy

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ced.14081

Reference5 articles.

1. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

2. Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria

3. Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study

4. IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria

5. Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insights into chronic inducible urticaria;Current Allergy and Asthma Reports;2024-07-19

2. Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment;The Lancet;2024-07

3. Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients;Journal of the European Academy of Dermatology and Venereology;2024-04-02

4. Atopy in chronic urticaria: an important yet overlooked issue;Frontiers in Immunology;2024-02-06

5. Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria;Journal of the European Academy of Dermatology and Venereology;2023-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3